Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;2(4):254-9.
doi: 10.4168/aair.2010.2.4.254. Epub 2010 Sep 6.

Effects of smoking cessation on airflow obstruction and quality of life in asthmatic smokers

Affiliations

Effects of smoking cessation on airflow obstruction and quality of life in asthmatic smokers

An-Soo Jang et al. Allergy Asthma Immunol Res. 2010 Oct.

Abstract

Purpose: Smoking elicits airway inflammation and airflow obstruction in patients with asthma, even after smoking cessation. The aim of this study was to examine the effects of smoking cessation on lung function and quality of life (QOL) in asthmatic patients.

Methods: Thirty-two patients with asthma who were active smokers were recruited. After education on the effects of smoking on asthma, 22 patients continued to smoke, and 10 quit smoking. All patients were treated with inhaled fluticasone propionate (1 mg/day) for 3 months. We compared forced expiratory volume in 1 s (FEV1), FEV1/forced vital capacity (FVC), forced expiratory flow between 25 and 75% FVC (FEF(25-75%)), and scores on a QOL questionnaire at baseline, 1, 2, and 3 months.

Results: Quitters showed a greater percent change in FEV1 (19.1±6.3 vs. 7.9±2.4%, P=0.024) and FEV1/FVC (6.5±4.14 vs. 3.5±1.5%, P=0.05) than smokers. Both quitters and smokers showed improved QOL scores after 1, 2, and 3 months of fluticasone treatment.

Conclusions: Patients with asthma who quit smoking showed less airway obstruction, suggesting that smoking cessation is crucial in the management of asthma.

Keywords: Smoking; asthma; lung function; quality of life.

PubMed Disclaimer

Conflict of interest statement

There are no financial or other issues that might lead to conflict of interest.

Figures

Fig. 1
Fig. 1
Study design.
Fig. 2
Fig. 2
Predicted FEV1 (A), FEV1/FVC (B), and FEF25-75% (C) values during inhaled steroid treatment in quitters and smokers.
Fig. 3
Fig. 3
Percent change in predicted forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC, and forced expiratory flow between 25 and 75% FVC (FEF25-75%) values in quitters and smokers at 1 month after initiating inhaled steroid treatment.
Fig. 4
Fig. 4
Changes in quality of life in quitters and smokers at 1, 2, and 3 months after initiating inhaled steroid treatment.

References

    1. Thomson NC, Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol. 2005;5:57–63. - PubMed
    1. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax. 2002;57:226–230. - PMC - PubMed
    1. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med. 2003;168:1308–1311. - PubMed
    1. Jang AS, Park JS, Lee JH, Park SW, Kim DJ, Uh ST, Kim YH, Park CS. The impact of smoking on clinical and therapeutic effects in asthmatics. J Korean Med Sci. 2009;24:209–214. - PMC - PubMed
    1. Silverman RA, Boudreaux ED, Woodruff PG, Clark S, Camargo CA., Jr Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest. 2003;123:1472–1479. - PubMed